Citatuzumab bogatox

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Citatuzumab bogatox
Monoclonal antibody
TypeFab fragment
SourceHumanized (from mouse)
TargetTACSTD1
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC3455H5371N921O1060S18
Molar mass77.3 kg/mol g·mol−1
 ☒N☑Y (what is this?)  (verify)

Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.[2]

References[edit]